Advertisement

Journal of Endocrinological Investigation

, Volume 41, Issue 3, pp 293–298 | Cite as

The effect of primary hyperparathyroidism on pancreatic exocrine function

  • P. Sisman
  • M. Avci
  • A. Akkurt
  • A. B. Sahin
  • O. O. Gul
  • C. Ersoy
  • E. Erturk
Original Article

Abstract

Background

Elastase-1 is a proteolytic enzyme secreted by pancreatic acinar cells, and measurements of the concentration this enzyme are used to evaluate pancreatic exocrine function. We aimed to determine whether pancreatic exocrine function declines due to chronic hypercalcemia by measuring fecal elastase levels.

Methods

75 patients with primary hyperparathyroidism (18 men and 47 women) and 30 healthy subjects (11 men and 19 women) participated in this study. Renal function tests, lipid parameters, bone mineral density, and serum calcium, phosphorus, vitamin D, parathormone, glucose, and thyroid stimulating hormone levels as well as fecal elastase concentrations, were determined in these patients and controls.

Results

The mean fecal elastase level was 335.3 ± 181.4 μg/g in the PHPT group and 317.4 ± 157.3 μg/g in the control group. There was no significant difference in fecal elastase levels between the two groups (p = 0.5).

Conclusions

Chronic hypercalcemia in primary hyperparathyroidism did not decrease the fecal elastase level, which is an indirect indicator of chronic pancreatitis; therefore, chronic hypercalcemia in PHPT may not cause chronic pancreatitis.

Keywords

Primary hyperparathyroidism Fecal elastase Pancreatic exocrine functions 

Notes

Compliance with ethical standards

Conflict of interest

The authors have no conflicts of interest to disclose.

Ethical approval

This study was approved by the Institutional Review Board of the Uludag University of the Turkey.

Human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Our research involved human participants who had obtained informed consent.

References

  1. 1.
    Naruse S, Ishiguro H, Ko SBH et al (2006) Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency. J Gastroenterol 41:901–908CrossRefPubMedGoogle Scholar
  2. 2.
  3. 3.
    Sziegoleit A (1984) A novel proteinase from human pancreas. Biochem J 219:735–742CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Stein J, Jung M, Sziegoleit A et al (1996) Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 42(2):222–226PubMedGoogle Scholar
  5. 5.
    Löser C, Mollgaard A, Folsch UR (1996) Faecal elastase 1: a novel, highly sensitive and specific tubeless pancreatic function test. Gut 39:580–586CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Dominic R, Franzini C (2002) Fecal Elastase-1 as a test for pancreatic function: a review. Clin Chem Lab Med 40(4):325–332Google Scholar
  7. 7.
    Shane E, Dinaz I (2006) Hypercalcemia: pathogenesis, clinical manifestations, differential diagnosis and management. In: Favus MJ (ed) Primer on the metabolic bone disease and disorders of mineral metabolism, 6th edn. Lippincott, Williams, and Wilkins, Philadelphia, p 176Google Scholar
  8. 8.
    Marcocci C, Brandi ML, Scillitani A et al (2015) Italian society of endocrinology consensus statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J Endocrinol Invest 38:577–593CrossRefPubMedGoogle Scholar
  9. 9.
    Mithöfer K, Fernandez-del Castillo C, Frick TW et al (1995) Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology 109(1):239–246CrossRefPubMedGoogle Scholar
  10. 10.
    Bhadada SK, Updawat HP, Bhansali A et al (2007) Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis. J Gastoenterol Hepatol 28:959–964Google Scholar
  11. 11.
    Jacob JJ, Chacko A, Selvan B et al (2008) Primary hyperparathyroidism and chronic pancreatitis. J Gastroenterol Hepatol 233:164Google Scholar
  12. 12.
    Niederle B, Roka R, Woloszczuk W (1987) Successful parathyroidectomy in primary hyperparathyroidism: a clinical follow-up study of 212 consecutive patients. Surgery 102(6):903–909PubMedGoogle Scholar
  13. 13.
    Bess MA, Edis AJ, van Heerden JA (1980) Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 243:246–247CrossRefPubMedGoogle Scholar
  14. 14.
    Carnaille B, Oudar C, Pattou F (1998) Pancreatitis and primary hyperparathyroidism: forty cases. Aust NZ J Surg 68(2):117–119CrossRefGoogle Scholar
  15. 15.
    Wolkowiak J, Nousia-Arvanitakis S, Cade A et al (2002) Fecal elastase-1 cut of levels in assessment of exocrine pancreatic function in cystic fibrosis. J Cystic Fibrosis 1(4):260–264CrossRefGoogle Scholar
  16. 16.
    Bauer S, Amman R (1994) Chronic pancreatitis and primary hyperparathyroidism. Scweiz Med Wochenschr 124(30):1344–1348Google Scholar
  17. 17.
    Ward JB, Peterson OH, Jenkins SA et al (1995) Is an elevated concentration of acinar cytosolic free ionized calcium the trigger for acute pancreatitis? Lancet 346:1016–1019CrossRefPubMedGoogle Scholar
  18. 18.
    Hart PA, Conwell DL (2015) Diagnosis of exocrine pancreatic insufficiency. Curr Treat Options Gastroenterol 13(3):347–353CrossRefPubMedGoogle Scholar
  19. 19.
    Mann ST, Stracke H, Lange U et al (2003) Alterations of bone mineral density and bone metabolism in patients with carious grades of chronic pancreatitis. Metabolism 52(5):579–585CrossRefPubMedGoogle Scholar
  20. 20.
    Moran CE, Sosa EG, Martinez SM et al (1997) Bone mineral density in patients with pancreatic insufficiency and steatorrea. Am J Gastroenterol 92:867–871PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2017

Authors and Affiliations

  • P. Sisman
    • 1
  • M. Avci
    • 2
  • A. Akkurt
    • 3
  • A. B. Sahin
    • 2
  • O. O. Gul
    • 4
  • C. Ersoy
    • 4
  • E. Erturk
    • 4
  1. 1.Endocrinology and Metabolism ClinicHarakani State HospitalKarsTurkey
  2. 2.Department Of Internal MedicineUludag University Medical SchoolBursaTurkey
  3. 3.Endocrinology and Metabolism ClinicMuradiye State HospitalBursaTurkey
  4. 4.Department of Endocrinology and MetabolismUludag University Medical SchoolBursaTurkey

Personalised recommendations